Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Edwards

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|May 8, 1999
Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cellsA Janowska-Wieczorek, L A Marquez, A Matsuzaki, et al.
British Journal of Cancer|February 9, 2006
Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinomaM J Wallard, C J Pennington, A Veerakumarasivam, et al.
British Journal of Cancer|April 17, 1999
Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomasP A Forsyth, H Wong, T D Laing, et al.
Psychopharmacology|June 1, 1994
Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramineK M Lawrence, C L Katona, M T Abou-Saleh, et al.
Blood Cancer Journal|March 11, 2017
PI3Kδ and PI3Kγ isoforms have distinct functions in regulating pro-tumoural signalling in the multiple myeloma microenvironmentR E Piddock, N Loughran, C R Marlein, et al.
British Journal of Cancer|June 2, 2005
Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissuesA C P Riddick, C J Shukla, C J Pennington, et al.
British Journal of Cancer|July 3, 2008
Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell linesG D Stewart, R J E Skipworth, C J Pennington, et al.
Journal of Public Health (Oxford, England)|April 11, 2021
Phase 2 of the Norwich COVID-19 testing initiative: an evaluationT Berger Gillam, J Chin, S Cossey, et al.
British Journal of Cancer|January 27, 2011
ERK5 signalling in prostate cancer promotes an invasive phenotypeA K Ramsay, S R C McCracken, M Soofi, et al.
British Journal of Cancer|June 9, 2012
mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinomaJ P Baren, G D Stewart, A Stokes, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|May 8, 1999
Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cellsA Janowska-Wieczorek, L A Marquez, A Matsuzaki, et al.
British Journal of Cancer|February 9, 2006
Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinomaM J Wallard, C J Pennington, A Veerakumarasivam, et al.
British Journal of Cancer|April 17, 1999
Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomasP A Forsyth, H Wong, T D Laing, et al.
Psychopharmacology|June 1, 1994
Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramineK M Lawrence, C L Katona, M T Abou-Saleh, et al.
Blood Cancer Journal|March 11, 2017
PI3Kδ and PI3Kγ isoforms have distinct functions in regulating pro-tumoural signalling in the multiple myeloma microenvironmentR E Piddock, N Loughran, C R Marlein, et al.
British Journal of Cancer|June 2, 2005
Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissuesA C P Riddick, C J Shukla, C J Pennington, et al.
British Journal of Cancer|July 3, 2008
Variation in dermcidin expression in a range of primary human tumours and in hypoxic/oxidatively stressed human cell linesG D Stewart, R J E Skipworth, C J Pennington, et al.
Journal of Public Health (Oxford, England)|April 11, 2021
Phase 2 of the Norwich COVID-19 testing initiative: an evaluationT Berger Gillam, J Chin, S Cossey, et al.
British Journal of Cancer|January 27, 2011
ERK5 signalling in prostate cancer promotes an invasive phenotypeA K Ramsay, S R C McCracken, M Soofi, et al.
British Journal of Cancer|June 9, 2012
mRNA profiling of the cancer degradome in oesophago-gastric adenocarcinomaJ P Baren, G D Stewart, A Stokes, et al.
Pageof 13